Ads
related to: monoclonal antibody
Search results
Jump Financial LLC Boosts Stock Holdings in Immunovant, Inc. (NASDAQ:IMVT)
ETF DAILY NEWS· 4 days agoJump Financial LLC grew its holdings in Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 141.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Q1 2024 Voyager Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 7 days agoAs Al mentioned, we're excited to announce that VY-TAU01, our anti-tau monoclonal antibody, obtained IND clearance. And we look forward to announcing, in ...
HC Wainwright Lowers Leap Therapeutics (NASDAQ:LPTX) Price Target to $5.50
ETF DAILY NEWS· 3 days agoLeap Therapeutics (NASDAQ:LPTX – Free Report) had its price objective decreased by HC Wainwright from $7.00 to $5.50 in a research note issued to investors on Tuesday, Benzinga reports. HC Wainwright ...
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WKRN Nashville· 22 hours agoHaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg ...
BioInvent to Present Additional Promising Phase 1/2a Data at EHA 2024 for BI-1206 with rituximab in...
Morningstar· 7 days agoFirst data for the SC arm: 1 complete response (CR), 2 partial response (PR), 1 stable disease (SD) out of 4 evaluable patients.Further updates from the IV arm; a fifth CR has been observed, ...
Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March...
FOX 23 News Albany· 6 days agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today said that they expect Leqembi...
Immunovant, Inc. (NASDAQ:IMVT) Short Interest Update
ETF DAILY NEWS· 4 days agoImmunovant, Inc. (NASDAQ:IMVT – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 8,960,000 shares, ...
HC Wainwright Cuts Cullinan Oncology (NASDAQ:CGEM) Price Target to $28.00
ETF DAILY NEWS· 2 days agoCullinan Oncology (NASDAQ:CGEM – Free Report) had its target price decreased by HC Wainwright from $29.00 to $28.00 in a report released on Thursday morning, Benzinga reports. HC Wainwright ...
KeyBanc maintains overweight rating on ABCL stock By Investing.com
Investing.com· 5 days agoOn Thursday, KeyBanc Capital Markets reaffirmed its positive stance on AbCellera Biologics...
Mount Sinai Awarded $6.6 Million From National Ins | Newswise
Newswise· 5 days agoNew York, NY – The Icahn School of Medicine at Mount Sinai Health System is spearheading a collaborative effort to investigate dupilumab as a treatment for children with alopecia areata, a disease ...
